← All organizations
Highest phase reached
Phase 3
First clinical trial
Mar 1, 2007Last known activity
Sep 1, 2011
Timeline
No events for the selected filters.
Drugs by trial phase (8 distinct, 3 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (4 own, 0 via acquisition)
Indications
Studied for
- Bronchiolitis
- Bronchiolitis Obliterans
- Communicable Diseases
- Cryptogenic Organizing Pneumonia
- Graft vs Host Disease
- Infections
- Leukemia
- Lung Diseases
- Lung Diseases, Interstitial
- Lymphoma
- Myelodysplastic Syndromes
- Myeloproliferative Disorders
- Neoplasm Metastasis
- Neoplasms
- Preleukemia
- Primary Myelofibrosis
- Respiratory Tract Infections
- Syndrome
Recent trials (3)
- NCT01432080CollaboratorPhase 2Sep 1, 2011
- NCT01217723CollaboratorPhase 3Apr 1, 2010
- NCT00438958Lead sponsorPhase 3Mar 1, 2007
Details
- Last known activity
- Sep 1, 2011